Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Parallel, Active Controlled Study to Compare Efficacy & Safety Between Ranibizumab 10mg/ml Injection of Incepta and Lucentis in Patients With Diabetic Macular Edema by ITV Injection
Conditions
Interventions
Ranibizumab 10mg/ml Injection
Lucentis
Locations
1
Bangladesh
Bangladesh Eye Hospital & Institute
Dhaka, Bangladesh
Start Date
March 30, 2024
Primary Completion Date
October 1, 2025
Completion Date
December 1, 2025
Last Updated
June 6, 2025
NCT07425522
NCT07308639
NCT07449936
NCT07449923
NCT07296952
NCT06439576
Lead Sponsor
Incepta Pharmaceuticals Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions